ArticleCell communication and signaling : CCS2026
Extracellular vesicle-associated PD-L1 induces CD4
Article in Cell communication and signaling : CCS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Decoding Immune Dysregulation in Sepsis Through Extracellular Vesicles: A Path to Precision Medicine.Pharmaceutics · 2026Review
- Mitochondrial dysfunction in sepsis-induced immunoparalysis: from immune-cell metabolic reprogramming to clinical biomarkers.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
backgroundThe upregulation of PD-1 on T lymphocytes is one of the key mechanisms driving sepsis-induced immunosuppression. Nevertheless although it is known that PD-L1 on antigen-presenting cells acts as a ligand for PD-1 on T lymphocytes, it remains to be determined whether extracellular vesicle-associated PD-L1 also serves as its ligand.
methodsPlasma extracellular vesicles (EVs) were isolated via ultracentrifugation. We evaluated the relationship of EV-associated PD-L1 level to immune function and prognosis in septic patients. Additionally, we observed the effect of EV-associated PD-L1 on the proliferation and immune function of co-cultured CD4+ T cells in vitro. We further verified the role of EV-associated PD-L1 by knocking down PD-L1 in a mouse model.
resultsThe peripheral circulating EV levels were significantly increased in septic patients compared with healthy volunteers. Enhanced PD-L1 protein content on these EVs was evident in septic patients, particularly in those exhibiting adverse prognostic features and pronounced immunosuppression. EVs secreted by LPS-stimulated monocytes were enriched with more PD-L1 than monocytes alone. Co-culture of CD4+ T cells with sepsis-derived EVs significantly downregulated the expression of CD69, IFN-γ and cell viability but upregulated the level of IL-4 and TGF-β. This was accompanied by heightened PD-1 expression and an increased Tregs/CD4+ T cell ratio. Conversely, this effect was partially reversed by inhibition of EV production or knockout of PD-L1 in EVs. Compared with LPS-treated EVs, PD-L1 knockout LPS-treated EVs alleviated the immunosuppressive state in CLP mice.
conclusionThe elevated level of circulating EV-associated PD-L1 was closely associated with poor prognosis and immunosuppression in septic patients. EV-associated PD-L1 engaged CD4+ T cells to induce CD4+ T cell dysfunction and may be one of the key mechanisms inducing immunosuppression in sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.